A Survey of Susoctocog Alfa (Genetical Recombination) in Participants With Acquired Haemophilia A
NCT06461533
·
clinicaltrials.gov ↗
RECRUITING
Status
25
Enrollment
INDUSTRY
Sponsor class
Conditions
Acquired Hemophilia A
Interventions
DRUG:
Susoctocog Alfa (Genetical Recombination)
Sponsor
Takeda